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Abstract Upon exposure to elevated temperatures, mammalian
cells increase the expression of the heat shock proteins (HSP)
through activation of the heat shock factor 1 (HSF1). Since
most transcription factors require coactivators for e⁄cient tran-
scriptional activity, we tried to identify the coactivator(s) that
interacts with and modulates the activities of HSF1. In vitro
glutathione S-transferase (GST) pull-down assay revealed that
HSF1 strongly interacts with activating signal cointegrator
(ASC)-2 and weakly with cyclic adenosine monophosphate re-
sponsive element binding protein (CBP). We also show that
cotransfection of ASC-2, but not CBP, potentiates HSF1-medi-
ated transactivation based on its cognate element (heat shock
element, HSE) linked to luciferase reporter. The molecular in-
teraction of HSF1 and ASC-2 was stimulated by heat shock in
cells and the overexpression of HSF1-interacting domain of
ASC-2 inhibited the speci¢c induced protein association and
HSF1-mediated transactivation. Taking these results together,
we suggest that ASC-2 in a novel coactivator for HSF1 and
heat shock stress may contribute the strong active transcription
complex through sequential recruitment of HSF1 and ASC-2.
/ 2004 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
When cells are exposed to stressful conditions such as heat
shock and heavy metals, they increase the expression of a
speci¢c set of proteins referred to as the heat shock proteins
(HSPs) that serve as chaperone by facilitating protein folding
and assembly and intracellular transport [1^4]. Increased ex-
pression of the HSPs in response to stresses is transcription-
ally mediated by the heat shock factor (HSF) [5,6]. HSF1, one
of the HSF families (HSF1^4), is known as a major mediator
for the heat shock response. HSF1 consists of the N-terminal
DNA binding domain (DBD), regulatory domain, and C-ter-
minal transactivation domain (TAD). In normal cells, HSF1
exists in complex with regulatory proteins such as HSP70 and
HSP90, which repress the DNA binding activity of HSF1 [7^
9]. Exposure of cells to proteotoxic stresses results in the ap-
pearance of non-native polypeptides and the requirement for
molecular chaperones. As a consequence of the release of
interacting chaperones, HSF1 monomer homotrimerizes,
translocates to nucleus, binds to the heat shock element
(HSE), composed of inverted repeats of the 5-bp sequence
5P-nGAAn-3P, and is hyperphosphorylated, and becomes tran-
scriptionally competent [10^14].
Most transcription factors require coactivators to exhibit
their full transcriptional activity. Cyclic adenosine monophos-
phate responsive element binding protein (CBP)/p300, one of
the major coactivators whose roles in the transcription are
widely studied, potentiates the transactivational activity of a
variety of transcription factors including nuclear receptors
and myoD [26,27]. Activating signal cointegrator (ASC)-2 is
¢rst known to identify as a transcriptional coactivator of nu-
clear receptors [28] and is introduced under di¡erent names by
others with variously termed TRBP, PRIP, and RAP250 [29^
31]. ASC-2, a typical ligand and AF2-dependent interactor of
nuclear receptors, enhances receptor transactivation, either
alone or in conjunction with SRC-1 and CBP/p300. ASC-2
can also mediate transactivation of a variety of transcription
factors including SRF, AP-1, and NF-UB in addition to nu-
clear receptors [32,33]. Certain functions of coactivators could
be modulated by a number of di¡erent signal transduction
pathways and external stimuli. For instance, CBP can be
stimulated to exert its histone acetyltransferase (HAT) enzy-
matic activity through phosphorylation by p44 extracellular
regulated kinase (ERK) and is calcium-sensitive such that it
may act as a regulatory switch for CaM kinase II, CaM ki-
nase IV, and protein kinase A-induced transcription [34].
SRC-1 is also phosphorylated by ERK1/2 in response to pro-
gesterone and EGF [35].
In this study, we tried to ¢nd out the coactivators that
interact with and modulate the activities of HSF1. Here we
show that HSF1 strongly interacts with coactivator ASC-2
and that expression of ASC-2 potentiates HSF1-mediated
transactivation based on HSE linked to luciferase reporter.
We further show that heat shock enhances the protein^protein
interaction of ASC-2 and HSF1 in cells.
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2. Materials and methods
2.1. Cell culture and heat shock treatment
HepG2 cells were grown in Dulbecco’s modi¢ed Eagle’s medium
(Life Technologies, Inc.) supplemented with 1% penicillin^streptomy-
cin (Life Technologies, Inc.) and 10% (v/v) fetal bovine serum (Life
Technologies, Inc.) at 37‡C in a humidi¢ed incubator with 5% CO2.
For heat shock treatment, cells were plated and stabilized for 24 h at
37‡C and then exposed to heat shock of 43‡C for 30 min and recov-
ered at 37‡C for several hours if that was required.
2.2. Plasmid constructs of HSF1
The GAL4N-HSF1 fusion proteins were constructed by ampli¢ca-
tion of HSF1 (amino acid residues 1^529, 1^399, and 395^529) using
speci¢c primers, and subcloned into plasmid pCMX-1, which encodes
GAL4N DBD (residues 1^147). The HSE-Luc was constructed by
ligating the 3122 to 390 fragment of the Hsp70 promoter
(3122GATCCGGCGAAACCCCTGGAATATTCCCCGACCT390)
into the heterologous reporter construct pGL2basic. pcDNA3/p38L
expression vector was kindly provided by Dr. Jiahuai Han (The
Scripps Research Institute, La Jolla, CA, USA).
2.3. Transient transfection and promoter analyses
The cells were plated at about 8U104 cells per 35 mm dish and
cultured for 24 h before transfection. After incubation, the cells were
transfected with 200 ng of L-galactosidase expression vector pSV110
and 200 ng of reporter gene, along with HSF1, ASC-2, or CBP ex-
pression vector using SuperFect or PolyFect as instructed by the
manufacturer (Qiagen). Total amounts of expression vectors were
kept constant by adding decreasing amounts of the pcDNA3 to trans-
fections. 2^3 h after transfection, the cells were washed and refed with
Dulbecco’s modi¢ed Eagle’s medium containing 10% fetal bovine se-
rum. Cells were harvested 44^48 h later, and luciferase activity was
assayed, and the results were normalized to the L-galactosidase ex-
pression. All the results represent the mean of three independent ex-
periments. The basal activity of the luciferase reporter in the presence
of empty expression vector was normalized to 1.0, and the activities of
the remaining transfection reaction were expressed relative to this, as
fold activation of the basal promoter.
2.4. Glutathione S-transferase (GST) pull-down assay
The GST-HSF1 fusion constructs or GST alone were expressed in
Escherichia coli, bound to glutathione-Sepharose-4B beads (Amer-
sham Pharmacia Biotech), and incubated with labeled proteins ex-
pressed by in vitro translation by using the TNT-coupled transcrip-
tion^translation system, under conditions as described by the
manufacturer (Promega) in GST pull-down reaction bu¡er (25 mM
HEPES, pH 7.6, 20% glycerol, 120 mM NaCl, 0.2 mM ethylenedi-
amine tetraacetic acid (EDTA), 1 mM dithiothreitol (DTT), 0.1%
Triton X-100, 0.1% bovine serum albumin) for 8 h at 4‡C. After
washing three times with PBST, the bound proteins were eluted
with 10 mM reduced glutathione in 50 mM Tris^Cl, pH 8.0, 120
mM NaCl and boiled with an equal volume of 2U LSB at 100‡C
for 3 min prior to electrophoresis. After electrophoresis, the gel was
dried and analyzed with the Molecular Imager Fx (Bio-Rad).
2.5. Coimmunoprecipitation assay between ASC-2 and HSF1
Nuclear extracts (500 Wg) were incubated with 20 Wg of anti-HSF1
IgG at 4‡C for 8 h with gentle agitation. Immune complexes were
washed three times with lysis bu¡er, the precipitates were boiled with
an equal volume of 2U LSB at 100‡C for 3 min and analyzed by 4
and 10% sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE).
2.6. Gel electrophoresis and Western blotting
Cells were washed in ice-cold phosphate-bu¡ered saline (PBS) and
lysed in ice-cold lysis bu¡er (150 mM NaCl, 1 mM EDTA, 1% Non-
idet P-40, 50 mM Tris^Cl, pH 7.5, 10% glycerol) containing 1 mM
DTT, 1% protease inhibitor cocktail (Sigma), and 1 mM phenylmeth-
ylsulfonyl £uoride (PMSF), 20 mM NaF and phosphatase inhibitor,
5 mM Na3VO3 at 4‡C for 15 min. The protein concentration of cell
lysates was determined with Bradford reagent (Bio-Rad) using bovine
serum albumin (BSA) as a standard. After heating at 100‡C for 3 min,
equal amounts of proteins was separated by SDS^PAGE. The result-
ing gels were either stained with Coomassie blue or transferred
to polyvinylidene di£uoride (PVDF) (Immobilon-P) membrane
(Schleicher and Schuell). For Western blotting, the membrane was
blocked with 1% skim milk in TBS-T (0.05% Tween-20 in TBS) for
1 h at room temperature on a shaker. After washing the membrane
with TBS-T, it was probed with antibodies to ASC-2 and TBP anti-
body (Santa Cruz Biotechnology) for 1 h at room temperature. After
washing the membrane with TBS-T three times, it was incubated with
1:2500 diluted horseradish peroxidase (HRP)-conjugated secondary
antibody and the proteins were visualized by the enhanced chemilu-
minescence detection system according to the recommended procedure
(Amersham Pharmacia Biotech).
2.7. Mammalian two-hybrid assay
HepG2 cells were seeded with growth medium supplemented with
10% fetal bovine serum (FBS) and 1% antibiotics, and cotransfected
with expression vectors encoding Gal4-DBD fusions (pCMX/Gal4N-,
pCMX/Gal4N-HSF1) and VP16 activation domain fusions (pCMX/
VP16/-, pCMX/VP16-ASC-2) as well as the previously described
Gal4-tk-luc reporter plasmid. After 48 h, cells were harvested and
the luciferase activity was normalized to the L-galactosidase expres-
sion. All the results represent the average of at least three independent
experiments.
2.8. Chromatin immunoprecipitation analysis
Cells were lysed for 5 min in L1 bu¡er (50 mM Tris pH 8.0, 2 mM
EDTA, 0.1% NP-40 and 10% glycerol) supplemented with protease
inhibitors. Nuclei were pelleted at 3000 rpm and resuspended in L2
bu¡er (50 mM Tris pH 8.0, 0.1% SDS and 5 mM EDTA). Chromatin
was sheared by sonication, centrifuged and diluted 10 times in dilution
bu¡er (50 mM Tris pH 8.0, 0.5% NP-40, 0.2 M NaCl and 0.5 mM
EDTA). Extracts were pre-cleared for 3 h with 60 Wl of a 50% sus-
pension of salmon sperm-saturated protein A agarose. Immunoprecip-
itations were carried out overnight at 4‡C. Immunocomplexes were
collected with salmon sperm-saturated protein A for 30 min and
washed three times (5 min each) with high-salt bu¡er (20 mM Tris
pH 8.0, 0.1% SDS, 1% NP-40, 2 mM EDTA and 0.5 M NaCl) fol-
lowed by three washes in no salt bu¡er (1U TE). Immunocomplexes
were extracted in 1U TE containing 2% SDS, and protein-DNA
cross-links were reverted by heating at 65‡C overnight. After protein-
ase K digestion, DNA was extracted with phenol^chloroform and
precipitated in ethanol. About one-twentieth of the immunoprecipi-
tated DNA was used in each polymerase chain reaction (PCR). The
PCR conditions were as follows: 1.25 U of Taq DNA polymerase
(Amersham Biosciences), 100 ng of each primer, 200 WM deoxyribo-
nucleoside triphosphate (dNTP), 2.5 Wl of 10U Taq bu¡er and dou-
ble-distilled water to a ¢nal volume of 25 Wl : 94‡C for 180 s; 34 cycles
at 94‡C for 45 s, 60‡C for 60 s and 72‡C for 60 s; ¢nal elongation at
72‡C for 10 min.
3. Results
3.1. Interaction between HSF1 and coactivators, ASC-2 and
CBP
As transcription factors require coactivators for their e⁄-
cient transcriptional activity, we tried to identify the coactiva-
tor(s) that interacts with and modulates the activities of
HSF1. From our preliminary experiments, ASC-2 coactivator
was phosphorylated by heat shock treatment (data not
shown). This ¢nding led us to examine a possibility that a
certain coactivator including ASC-2 be involved in HSF1-in-
volved transcriptional regulation mediated by heat shock. To
¢nd out coactivator(s) that interacts with HSF1, we per-
formed GST pull-down assay in vitro. GST alone and GST
fusion to HSF1 were expressed in E. coli, puri¢ed, and incu-
bated with coactivators including CBP, SRC-1, ASC-1 and
ASC-2, which were transcribed and translated in vitro using
rabbit reticulocyte lysates. In vitro GST pull-down assay re-
vealed that GST-HSF1 fusion protein, but not GST alone,
strongly interacts with coactivator ASC-2 and moderately
with CBP (Fig. 1). In comparison to the input (¢rst lane in
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Fig. 1), ASC-2 and CBP were retained by the hybrid GST-
HSF1 protein. In contrast, ASC-1 and SRC-1 did not asso-
ciate with HSF1 under experimental condition employed in
this study (Fig. 1).
3.2. E¡ects of coactivator overexpression on HSF1-mediated
transactivation
To study the involvement of the coactivators, ASC-2 and
CBP, on transactivation of gene expression by HSF1, it was
employed transfection experiments employing the Gal4 full-
length (amino acid residues 1^529), Gal4 N-terminal DBD
(1^399 amino acids), or Gal4 C-terminal TAD (395^529 ami-
no acids) of HSF1. Brie£y, this system employs an expression
plasmid encoding each domain and full length of HSF1 fused
to the DBD of Gal4 and a Gal4 responsive reporter plasmid,
Gal-luciferase. The advantage of this assay is that Gal4-
HSF1/TADð395529Þ is exclusively nuclear and is regulated in-
dependently with phosphorylation on DBD of HSF1, allow-
ing the e¡ects of genes of interest on transactivation by HSF1
to be assessed. The TAD alone of HSF1 showed a full trans-
activation of Gal4 element-linked luciferase reporter, whereas
the DBD and full length of HSF1 did not activate transcrip-
tion relative to that of the TAD (data not shown). For sub-
sequent transfection experiments, we used the Gal4 fused to
HSF1-TAD construct as an activator. HepG2 cells were
transfected with mammalian expression plasmids encoding
Gal4N-HSF1 and coactivators, ASC-2 and CBP, along with
Gal4 binding element-conjugated luciferase reporter. As
shown in Fig. 2A, cotransfection of ASC-2 with HSF1-TAD
showed an increased transcriptional activity synergistically but
CBP overexpression did not enhance HSF1-dependent trans-
activation.
We con¢rmed the enhanced HSF1-mediated transactivation
by ASC-2 through a transient transfection experiment using
full-length HSF1 expression plasmid and HRE-Luc reporter
gene with the plasmids encoding ASC-2 and CBP. ASC-2
enhanced the HSF1-mediated activation of transcription
with a two-fold di¡erence, but CBP alone did not show the
synergistic e¡ect on the transactivation of HSF1 (Fig. 2B).
Taken together the results of Figs. 1 and 2, it is suggested
that ASC-2 directly associates with HSF1 and activates
HSF1-driven transcription as a coactivator.
3.3. Delineation of HSF1-interacting region of ASC-2
Since ASC-2 coactivator cooperatively increased the HSF1-
mediated transactivation (Fig. 2), we focused the physical in-
teraction of HSF1 and ASC-2 protein for the synergistic
transactivation. To identify the interaction region of two pro-
teins, GST pull-down experiment was employed using in vitro
translated ASC-2 constructs and glutathione resin-conjugated
GST-HSF1 proteins. The full-length ASC-2 protein (amino
acids 1^2063) speci¢cally interacted with HSF1 protein (Fig.
3A). Subsequently, it was carried out to further identify the
HSF1-interacting region of ASC-2 through the same experi-
ments using ASC-2-deleted mutants. As shown in Fig. 3,
HSF1 protein interacted with the C-terminal domain (co4.5)
of ASC-2 speci¢cally and also weakly with the N-terminal one
(co1). The co4.5 domain of ASC-2 was also identi¢ed with an
interaction region for TBP, TFIIA, CBP, and SRC-1 [28,33].
The reciprocal strategy was used to delineate the region of
Fig. 1. Interaction between HSF1 and coactivators, CBP and ASC-
2. Equal amounts (1 Wg) of glutathione agarose-immobilized GST
and GST-HSF1 proteins were incubated with 35S-radiolabeled full-
length CBP, SRC-1, ASC-1 or ASC-2. After being washed three
times, the bound proteins were eluted with reduced glutathione, re-
solved by SDS^PAGE, and analyzed with autoradiography. The in-
put lanes represent V25% of the total protein.
Fig. 2. ASC-2 synergistically increases HSF1-mediated transactiva-
tion. A: Coactivator ASC-2 e¡ectively increases HSF1-mediated
transactivation. HepG2 cells were cotransfected with plasmids en-
coding Gal4-HSF1/TAD, CBP or ASC-2, along with a Gal4-tk
based reporter construct. After 48 h post-transfection, cells were
harvested for measurement of luciferase activity. B: HepG2 cells
were cotransfected with plasmids encoding full-length HSF1, CBP
or ASC-2, along with HRE reporter construct. Luciferase activity
was determined in cell lysates 48 h later, and the values ( TS.E.M.)
from at least two independent experiments performed in triplicate
are shown in the form of a bar graph.
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HSF1 required for interaction with ASC-2. After preparing
GST-HSF1-deleted proteins (HSF1-D1, 1^201; HSF1-D2,
201^370; HSF1-D3, 370^529) from E. coli, the proteins
were immobilized on glutathione-Sepharose beads and incu-
bated with in vitro translated 35S-labeled full-length ASC-2.
The labeled ASC-2 strongly associated with the C-terminal
activation domain of HSF1, but not with the N-terminal
DBD and central regulatory domain (Fig. 3B). These results
indicate that the C-terminal region of ASC-2 speci¢cally in-
teracts with the activation domain of HSF1.
3.4. Heat shock treatment increases the protein interaction of
HSF1 and ASC-2 in vivo
The association between HSF1 and ASC-2 was further
characterized by coimmunoprecipitation analysis. HSF1 was
immunoprecipitated from freshly prepared HepG2 nuclear ex-
tracts, gel-fractionated, and analyzed for ASC-2 coprecipita-
tion by Western blotting with anti-ASC-2 antibody. As shown
in Fig. 4A, endogenous ASC-2 was detected as a coprecipitant
in HSF1 immunoprecipitates. A parallel immunoprecipitate
formed with preimmune serum failed to show ASC-2 immu-
Fig. 3. Delineation of each interacting region of HSF1 and ASC-2 proteins. A: Delineation of HSF1-interacting region of ASC-2. GST-HSF1
protein was puri¢ed from E. coli and conjugated with glutathione resin. 35S-labeled in vitro translated ASC-2-deleted mutants were produced
using rabbit reticulocyte lysates. After being washed three times, the bound proteins were eluted with reduced glutathione, resolved by SDS^
PAGE, and analyzed with autoradiography. The input lanes represent 20% of the total protein. The diagram at bottom part shows the sche-
matic representation of coactivator ASC-2, in which the N-terminal acidic (D/E), glutamine-rich (Q-rich), receptor-interacting (RID), glutamine/
proline-rich (Q/P-rich) and serine/threonine-rich (S/T-rich) sequences are indicated with arrows. B: Delineation of ASC-2-interacting region of
HSF1. GST-HSF1-deleted proteins (designated with D1, D2, and D3) were puri¢ed from E. coli and conjugated with glutathione resin. 35S-la-
beled in vitro translated ASC-2 protein was produced using rabbit reticulocyte lysates. After being washed three times, the bound proteins were
eluted with reduced glutathione, resolved by SDS^PAGE, and analyzed with autoradiography. The input lanes represent 20% of the total pro-
tein. The diagram at bottom part shows the schematic representation of HSF1, in which the DBD, trimerization domain (TD), regulatory do-
main (RD), and activation domain (AD) are indicated.
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noreactivity (Fig. 4A, second lane). There is a possibility that
HSF1 e⁄ciently associates with ASC-2 dependent on extra-
cellular and endogenous signals. Since heat shock stress is a
representative extracellular signal for HSF1-mediated gene ac-
tivation, we examined the protein association of HSF1 and
ASC-2 using in vivo protein interaction assays after treating
heat shock. The heat shock treatment potently increased the
association of HSF1 and ASC-2 in cells (Fig. 4A, fourth lane).
We con¢rmed the in vivo protein interaction of HSF1 and
ASC-2 in cells via mammalian two-hybrid assay using GAL4-
HSF1 and VP16-ASC-2 expression plasmids in the presence
or absence of heat shock treatment. As a result of direct
interaction in vivo, heat shock treatment increased e⁄ciently
the molecular interaction of GAL4-HSF1 and VP16-ASC-2
approximately 19-fold (Fig. 4B). The transient overexpression
of HSF1-interacting region (ASC-2d, amino acids 1429^2063)
of ASC-2 inhibited the increased protein interaction of HSF1
and ASC-2 by heat shock. These results are consistent with
the interpretation that HSF1 is capable of associating with
ASC-2 in vitro and in vivo and that heat shock enhances
the protein interaction between HSF1 and ASC-2 in cells.
In addition, the HSF1-interacting region (ASC-2d) of ASC-
2 acted as a dominant negative mutant in HSF1-mediated
transactivation in the presence or absence of ectopic ASC-2
overexpression, as shown in Fig. 4C. This evidence provides a
more convincing result that explains the ASC-2 enhancement
of HSF1-mediated transactivation by the protein^protein in-
teraction in cells.
In order to determine whether ASC-2 is directly recruited to
HSF1-dependent promoter in the heat shock-treated cells,
ChIP analysis was performed. After heat shock treatment,
cells were lysed and solubilized chromatin was immunoprecip-
itated, initially with antibodies against HSF1 or ASC-2, and
recovered DNAs were ampli¢ed by PCR using promoter-spe-
ci¢c primers. It is clear from the data in Fig. 4D that ASC-2
recruitment to the HSF1-recognized promoter was con¢rmed
in cells. Collectively, these ¢ndings support the notion that
heat shock controls the recruitment of essential components
of the transcriptional activation machinery and consequently
the e⁄ciency of HSF1-dependent transcriptional activation.
4. Discussion
Most transcriptional factors require coactivators for their
full activities. In this study, we investigated the coactivators
that interact with and modulate the transcriptional activity of
HSF1. In vitro GST pull-down assay and coimmunoprecipi-
tation revealed an intact interaction between HSF1 and coac-
tivators, CBP and ASC-2 (Figs. 1 and 4A). In addition, co-
transfection of ASC-2, but not CBP, with HSF1 showed an
increased transcriptional activity dependently of HSF1 (Fig.
2), indicating that ASC-2 acts as a coactivator of HSF1. ASC-
2 has been demonstrated to control other transcriptional fac-
tors such as mitogenic transcription factors, including AP-1,
NF-UB, and SRF as well as the nuclear hormone receptor
superfamily [33]. This is the ¢rst report that ASC-2 may en-
hance HSF1-driven transcriptional activity.
Fig. 4. Heat shock treatment increases the protein interaction of
HSF1 and ASC-2 in vivo. A: Coimmunoprecipitation of endoge-
nous HSF1 and ASC-2. HepG2 cells were exposed to heat shock of
43‡C for 30 min or not. Nuclear extracts (500 Wg) were incubated
with 20 Wg of anti-HSF1 IgG or preimmune IgG and immune com-
plex was subjected to electrophoresis and Western blot analysis with
anti-ASC-2 antibody. B: The mammalian expression plasmids en-
coding GAL-HSF1 and VP16-ASC-2 or the empty vector of GAL
and VP16 were transfected into HepG2 cells with or without the
transient expression of HSF1-interacting ASC-2 construct (ASC-2d).
48 h after transfection in the absence or presence of heat shock,
cells were harvested for luciferase activities. All the transfection re-
sults were normalized to L-galactosidase activity, and the presented
results represented the average of three independent experiments,
with fold induction over the level observed with the reporter alone.
H, HSF1; A, ASC-2. C: The HSF1-interacting region of ASC-2
plays a role as a dominant negative protein in HSF1-mediated
transactivation. HepG2 cells were transfected with expression plas-
mids (each 1 Wg) HSF1, ASC-2, and/or increasing amounts of ASC-
2d (amino acids 1429^2063) (1, 2, and 4 Wg) as indicated and the
HSE promoter-luciferase reporter, as indicated. 48 h after transfec-
tion, cells were harvested and luciferase activity was determined. D:
ChIP analysis of factor occupancy on HSE promoters. Following
formaldehyde cross-linking, soluble chromatin was prepared. After
IP with antibodies against the indicated proteins (HSF1 and ASC-
2), precipitated DNAs were used in PCR analysis. Input shows the
starting chromatin extracts.
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In unstressed cells, HSF1 is constitutively phosphorylated
on serine residues 303, 307, and 363 in the regulatory domain
by glycogen synthase kinase-3L, ERK, c-Jun N-terminal ki-
nase/protein kinase C, respectively [15^21], which repress the
transcriptional activity of HSF1. HSF1 can be hyperphos-
phorylated in response to proteotoxic stresses such as heat
shock and heavy metals. Hyperphosphorylation of HSF1 in-
volves in the acquisition of transactivation function and in the
activation of the factor without a¡ecting HSF1 trimerization
and DNA binding activity [22^24]. Recently, CaM kinase II
has been demonstrated to be responsible for the HSF1 hyper-
phosphorylation and activation [25]. In addition, the HSP
expression in response to stresses such as heavy metals and
hypoxia has been suggested to be regulated by p38 kinase that
is one of mitogen-activated protein kinase family proteins,
and has been implicated in a variety of cellular functions
such as cell proliferation, di¡erentiation, and apoptosis,
although its precise role in the stress response has been not
well elucidated. In contrast, the roles of p38 kinase in HSF1
activation have been not well investigated. Since pro¢le of
p38L kinase activation in response to heat shock pro¢le is
very similar to that of HSF1 hyperphosphorylation (data
not shown) and both HSF1 and ASC-2 proteins possess the
tentative phosphorylation sites for p38 kinase, we speculated
that p38L may be linked to HSF1 transcriptional activation.
For active transcription process upon stress signaling, chro-
matin modi¢cation by several coactivators including CBP/
p300, P/CAF, and SRC-1 may be necessary [36,37]. Although
ASC-2 has a homology with the activation domain of CBP/
p300, it lacks an inherent HAT activity. As CBP/p300 was
found to interact with ASC-2, the recruitment of ASC-2
into HSF1 transcription complex may drive active chromatin
structure for transcription by HAT proteins, such as CBP/
p300. Finally, it is interesting to note that the HSP promoter
may be a typical enhancesome, comprised of a series of cis
elements, including binding sites for HSF family proteins and
several di¡erent classes of transcription factors. Our ¢nding
that ASC-2 interacts with HSF1 protein may shed some light
into how the HSP enhancesome is regulated upon stresses,
since ASC-2 functionally associates with other classes of tran-
scription factors including AP-1, SRF, NF-UB, and nuclear
receptors [33]. ASC-2 can stabilize the assembly of HSP en-
hancesome through association with HSF1 and other tran-
scription factors. In addition, ASC-2 may enhance the func-
tion of HSP enhancesome by juxtaposing components of the
transcriptional machinery in a more favorable orientation,
and may also play a role in recruiting transcriptional coacti-
vators. Perhaps one mechanism by which p38 kinase increases
the transactivation potential of ASC-2 is to promote the in-
teraction of ASC-2 with these members of the transcriptional
basal machinery. It should be interesting in the future to test
directly these possibilities.
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